Institution
USC Norris Comprehensive Cancer Center
Also known as: Keck Hospital of USC Norris Comprehensive Cancer Center · USC Norris Cancer Hospital · University of Southern California Norris Comprehensive Cancer Center
- 336running trials
- 109closed trials
- 10,714publications (OpenAlex)
Running trials
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Active, not recruiting
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Recruiting
Recruiting
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Active, not recruiting
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Showing 50 of 336.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer30 recruiting
- Colorectal cancer24 recruiting
- Bladder cancer16 recruiting
- Liver and biliary tract cancer15 recruiting
- Prostate cancer15 recruiting
- Head and neck cancer14 recruiting
- Melanoma14 recruiting
- Gastric and oesophageal cancer11 recruiting
- Ovarian cancer11 recruiting
- Kidney cancer10 recruiting
- Pancreatic cancer9 recruiting
- Childhood cancers8 recruiting
- Sarcoma8 recruiting
- Triple-negative breast cancer8 recruiting
- Acute myeloid leukaemia6 recruiting
- Immune thrombocytopenia (ITP)6 recruiting
- Metastatic breast cancer5 recruiting
- Endometrial cancer4 recruiting
- Neuroendocrine tumours4 recruiting
- Brain metastases2 recruiting
- Cervical cancer2 recruiting
- Glioblastoma2 recruiting
- Mesothelioma2 recruiting
- Multiple myeloma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Epidermolysis bullosa1 recruiting
- Testicular cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Terminated
Completed
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
Terminated
Terminated
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Completed
Terminated
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Terminated
Terminated
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Terminated
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
Withdrawn
Terminated
Terminated
Completed
Terminated
Terminated
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Withdrawn
sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer
Terminated
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
Completed
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
Terminated
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Terminated
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Completed
Recruiting
Completed
Completed
Completed
Recruiting
Terminated
Recruiting
Terminated
Terminated
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Terminated
Completed
Terminated
Completed
Terminated
Terminated
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
Terminated
Completed
Completed
Terminated
Terminated
Completed
Completed
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
Completed
Terminated
Completed
Completed
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Terminated
Completed
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
Terminated
Showing 50 of 109.
Registry name variants (31)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
USC / Norris Comprehensive Cancer Center
Los Angeles, California 90033
398 trials
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, California 90033
19 trials
University of Southern California (USC) - Norris Comprehensive Cancer Center
Los Angeles, California 90033
3 trials
USC Norris Cancer Hospital
Los Angeles, California 90033
3 trials
USC/Norris Comprehensive Cancer Center/Investigational Drug Services
Los Angeles, California 90033
2 trials
USC Norris Comprehensive Cancer Center - Keck Medicine of USC
Los Angeles, California 90033
2 trials
NCT06948318A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Contact: Howard Liebman (principal investigator)
NCT06722235A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Contact: Howard Liebman (principal investigator)
Usc Norris Comprehensive Cancer Center (Nccc)
Los Angeles, California 90089-1019
2 trials
USC Norris Comprehensive Cancer Center- Site Number : 8400002
Los Angeles, California 90033
2 trials
Institute of Urology, USC Norris Comprehensive Cancer Center
Los Angeles, California 90089
1 trial
Norris Comprehensive Cancer Center at USC
Los Angeles, California 90033
1 trial
Norris Comprehensive Cancer Center (USC)
Los Angeles, California 90033
1 trial
University of Southern California Norris Comprehensive Cancer Center, 1441 Eastlake Ave.
Los Angeles, California 90033
1 trial
University of Southern California Norris Comprehensive Cancer Center/ Hoag
Los Angeles, California 90033
1 trial
University of Southern California Norris Comprehensive Cancer Center (Site 1850)
Los Angeles, California 90033
1 trial
University of Southern California (USC) Norris Comprehensive Cancer Center Site Number: 8400015
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Newport Beach, California 92663
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center (Melanoma/NSCLC)
Los Angeles, California 90033
1 trial
NCT06060613Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Contact: Sandy Tran
USC/Norris Comprehensive Cancer Center (Site 0013)
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center (Site 0038)
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center (Site 0060)
Los Angeles, California 90033
1 trial
USC Norris Comprehensive Cancer Center (Site 0123)
Los Angeles, California 90033
1 trial
Contact: Study Coordinator
USC Norris Comprehensive Cancer Center (Site 0126)
Los Angeles, California 90033
1 trial
Contact: Study Coordinator
USC Norris Comprehensive Cancer Center (Site 0205)
Los Angeles, California 90033
1 trial
USC /Norris Comprehensive Cancer Center University of Southern California
Los Angeles, California 90033
1 trial
NCT04173650MSC EVs in Dystrophic Epidermolysis Bullosa
Contact: Mei Chen, PhD
USC Norris/Comprehensive Cancer Centre
Los Angeles, California 9003308
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Colorectal cancer77 works · 65 trials
- Bladder cancer43 works · 44 trials
- Acute lymphoblastic leukaemia13 works · 4 trials
Institution data: ROR 01nmyfr60 (CC0-1.0)Updated 15 Nov 2026